Listen to the article
0:00
Dans un entretien au « Monde », Leïla Chaouachi, docteure en pharmacie, estime qu’il n’est pas possible d’« endiguer ces crimes si l’on ne met pas en place une vigilance collective sur le sujet ».
15 commentaires
I like the balance sheet here—less leverage than peers.
Nice to see insider buying—usually a good signal in this space.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
The cost guidance is better than expected. If they deliver, the stock could rerate.
Interesting update on Soumission chimique : « La première chose que je dis aux victimes, c’est de croire en soi et en ses doutes ». Curious how the grades will trend next quarter.
Good point. Watching costs and grades closely.
Silver leverage is strong here; beta cuts both ways though.
Good point. Watching costs and grades closely.
The cost guidance is better than expected. If they deliver, the stock could rerate.
Good point. Watching costs and grades closely.
Production mix shifting toward Société might help margins if metals stay firm.
Good point. Watching costs and grades closely.
Production mix shifting toward Société might help margins if metals stay firm.
Good point. Watching costs and grades closely.